Back to top

Analyst Blog

Revenue Pre-Announcement Beats Our Estimate. Increasing Price Target to $0.70/share

By Brian Marckx, CFA

This morning (1/7/13) BioLife (OTC Markets:(BLFS)) pre-announced that Q4 and full-year 2012 revenue are expected to be approximately $2.0 million (~ +158%) and $5.7 million (~ +107%), respectively, which are well ahead or our $1.4 million and $5.0 million estimates.  Q4 and 2012 revenue will be a quarterly and annual record for BLFS.  This will mark the 10th consecutive quarter that BioLife turned in record revenue and equates to 34% CAGR of revenue since 2007.  This morning's press release also notes that Q4 is expected to show positive cash flow from operations.

Management continues to expect strong growth in 2013 from their regenerative medicine business and notes that they are pursuing additional contract manufacturing opportunities.  We have updated our model for today's revenue pre-announcement and will do so again when BLFS files their 10-K which is expected by April 1.    

We are maintaining our Outperform rating.  The update to our model along with an increase in comp multiples since our last update has moved our price target up from $0.50/share to $0.70/share.  See our valuation methodology and comp cohort as well as our financial model in our full report on BLFS available here

 For additional research on small-cap stocks, please visit

To become a subscriber to Zacks SCR and receive SCR blogs and research reports emailed directly to your inbox, please visit our Subscribe page.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
TRIQUINT SE… TQNT 20.68 +6.55%
RF MICRO DE… RFMD 12.45 +5.82%
VASCO DATA… VDSI 14.80 +4.89%
CHYRONHEGO… CHYR 2.85 +4.78%
PLANAR SYST… PLNR 4.99 +2.15%